SARS-CoV-2 Antibody Test
- UID
- IMP/IVD/2020/000402_5b13e39dd159a6f75b63c2f8306d4824_c0c77af48c5719e17ad1ea855b3bf15e
- Device class
- Class C
- Brand name
- colloidal gold immunochromatography
- License holder
- N.W. OVERSEAS
- Approving authority
- CDSCO
- Product information
- The product is intended for the qualitative detection of antibody content against SARS-CoV-2 in clinical samples (colloidal gold immunochromatography).
SARS-CoV-2 Antibody Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000402_5b13e39dd159a6f75b63c2f8306d4824_c0c77af48c5719e17ad1ea855b3bf15e. This device is marketed under the brand name colloidal gold immunochromatography. The license holder is N.W. OVERSEAS, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.